Akoya Biosciences, Inc. financial data

Symbol
AKYA on Nasdaq
Industry
Laboratory Analytical Instruments
Location
100 Campus Drive, 6 Th Floor, Marlborough, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 314 % -0.84%
Quick Ratio 61.7 % +47.8%
Debt-to-equity 284 % +57.2%
Return On Equity -141 % -14.7%
Return On Assets -36.8 % +16.2%
Operating Margin -57.6 % +31%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.5M shares +1.14%
Common Stock, Shares, Outstanding 49.5M shares +1.32%
Entity Public Float 186M USD -15.9%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 49.4M shares +21.6%
Weighted Average Number of Shares Outstanding, Diluted 49.4M shares +21.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 93.2M USD +9.66%
Cost of Revenue 39.6M USD +5.09%
Research and Development Expense 19.4M USD -22.9%
Operating Income (Loss) -53.7M USD +24.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -60.2M USD +21%
Income Tax Expense (Benefit) 103K USD +145%
Net Income (Loss) Attributable to Parent -60.4M USD +21%
Earnings Per Share, Basic -1.18 USD/shares +39.8%
Earnings Per Share, Diluted -1.18 USD/shares +39.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 8.92M USD -90.4%
Marketable Securities, Current 36.3M USD
Cash, Cash Equivalents, and Short-term Investments 48.7M USD
Accounts Receivable, after Allowance for Credit Loss, Current 16.6M USD +28.7%
Inventory, Net 24.8M USD +53.7%
Other Assets, Current 2.94M USD -23.6%
Assets, Current 89.5M USD -29.1%
Property, Plant and Equipment, Net 8.16M USD -26.7%
Operating Lease, Right-of-Use Asset 5.15M USD -46.5%
Intangible Assets, Net (Excluding Goodwill) 16M USD -16.4%
Goodwill 18.3M USD 0%
Other Assets, Noncurrent 647K USD -6.91%
Assets 144M USD -23.9%
Accounts Payable, Current 9.79M USD -16.6%
Employee-related Liabilities, Current 4.86M USD -29.1%
Accrued Liabilities, Current 13.2M USD -10.6%
Contract with Customer, Liability, Current 6.46M USD -10.4%
Liabilities, Current 32.7M USD -12.4%
Contract with Customer, Liability, Noncurrent 3.17M USD +27.1%
Deferred Income Tax Liabilities, Net 75K USD -13.8%
Operating Lease, Liability, Noncurrent 5.16M USD -28.9%
Other Liabilities, Noncurrent 40K USD
Liabilities 121M USD +3.86%
Accumulated Other Comprehensive Income (Loss), Net of Tax -12K USD
Retained Earnings (Accumulated Deficit) -267M USD -29.2%
Stockholders' Equity Attributable to Parent 22.2M USD -69.1%
Liabilities and Equity 144M USD -23.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -20.8M USD -5.4%
Net Cash Provided by (Used in) Financing Activities -444K USD -5.97%
Net Cash Provided by (Used in) Investing Activities -48.8M USD -888%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 49.5M shares +1.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -70.1M USD -401%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.63M USD -89.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.24M USD +25.1%
Deferred Tax Assets, Valuation Allowance 51.4M USD +35.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 53.5M USD +30.2%
Operating Lease, Liability 7.84M USD -22.8%
Payments to Acquire Property, Plant, and Equipment 810K USD +0.75%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -60.4M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid 9.03M USD -24.5%
Property, Plant and Equipment, Gross 18M USD -5.79%
Operating Lease, Liability, Current 2.68M USD -7.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.64M USD -7.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.84M USD +2.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 37K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.19M USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.1M USD -58.1%
Deferred Tax Assets, Operating Loss Carryforwards 31.4M USD +17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.14M USD +22.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 436K USD -60.5%
Operating Lease, Payments 718K USD -4.65%
Additional Paid in Capital 289M USD +3.85%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.05M USD -3.3%
Deferred Tax Assets, Net of Valuation Allowance 2.14M USD -33.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%